TG THERAPEUTICS, INC. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/36886799-896b-4dd6-be11-000a072f7d32/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $447.2M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-014233 |
| FY 2024 | $23.4M | 2024-01-01 – 2024-12-31 | evidence 0001437749-26-014233 |
| FY 2023 | $12.7M | 2023-01-01 – 2023-12-31 | evidence 0001437749-26-014233 |
| FY 2022 | $-198.3M | 2022-01-01 – 2022-12-31 | evidence 0001437749-26-014233 |
| FY 2021 | $-348.1M | 2021-01-01 – 2021-12-31 | evidence 0001437749-26-014233 |
| FY 2013 | $-47.0M | 2011-12-01 – 2014-03-31 | evidence 0001144204-14-030472 |
| FY 2012 | $-22.6M | 2011-12-01 – 2013-03-31 | evidence 0001144204-13-028722 |
| FY 2011 | $-11.1M | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-028735 |
| FY 2010 | $623.6k | 2010-01-01 – 2010-12-31 | evidence 0001144204-11-052935 |
| FY 2009 | $-2.8M | 2009-01-01 – 2009-12-31 | evidence 0001144204-11-052935 |
| FY 2008 | $-4.3M | 2008-01-01 – 2008-12-31 | evidence 0001144204-11-052935 |
| FY 2007 | $-12.0M | 2007-01-01 – 2007-12-31 | evidence 0001144204-11-052935 |
| FY 2006 | $-9.7M | 2006-01-01 – 2006-12-31 | evidence 0001144204-11-052935 |
| FY 2005 | $-19.1M | 2005-01-01 – 2005-12-31 | evidence 0001144204-11-052935 |
| FY 2004 | $-5.9M | 2004-01-01 – 2004-12-31 | evidence 0001144204-11-052935 |
| FY 2003 | $-6.0M | 2003-01-01 – 2003-12-31 | evidence 0001144204-11-052935 |
| FY 2002 | $-1.0M | 2002-01-01 – 2002-12-31 | evidence 0001144204-11-052935 |
| FY 2001 | $-56.8k | 2001-01-01 – 2001-12-31 | evidence 0001144204-11-052935 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TG THERAPEUTICS, INC. — all facts · Revenue · Operating Income